Dermagnostix kündigt Übernahme und Fortführung der Fluoreszenzdetektor Technologie von Dialunox zum 01.07.2025 an

Freiburg im Breisgau, 05.05.2025 – Die Dermagnostix GmbH aus Freiburg, spezialisiert auf die Entwicklung molekulardiagnostischer Tests für dermatologische Fragestellungen, erweitert…

Dermagnostix CEO Prof. Dr. Natalie Garzorz-Stark Wins Innovation Award Dermatology by BVDD e.V.

Dermagnostix CEO and Co-founder Prof. Dr. Natalie Garzorz Stark has been awared the Innovation Award Dermatology by Bundesverband der Deutschen…

State Parliament President Muhterem Aras and Member of Parliament Nadyne Saint-Cast Visit Dermagnostix in Freiburg

The President of the Baden-Württemberg Parliament, Muhterem Aras, and Nadyne Saint-Cast, Member of Parliament, recently visited Dermagnostix at its offices…

First On-Demand Webinar “Pattern in Inflammatory Skin Diseases”

We are excited to announce the launch of our new webinar series “Beyond the Surface: Revolutionizing Skin Diagnostics Through Molecular…

Dermagnostix at MEDICA 2024

Dermagnostix has been selected by the EIC- International Fairs 3.0 Programme as a startup with groundbreaking innovation for MEDICA 2024…

Dermagnostix on tour in June 2024

June was packed with exciting events and we had a great time exhibiting at ADH annual meeting in Göttingen as…

Dermagnostix GmbH announces product launch of PsorX®-LabDisk (CE-IVD) after successful pilot customer phase

Dermagnostix announces the official launch of the PsorX®-LabDisk. After the market entry with CE-IVD certification in 2022 and a following…